Drug Shortage Report for GALLIUM
| Report ID | 81842 |
| Drug Identification Number | Not Applicable/non applicable |
| Brand name | GALLIUM |
| Common or Proper name | Gallium Citrate Ga-67 Injection |
| Company Name | LANTHEUS MI CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | GALLIUM CITRATE GA 67 |
| Strength(s) | 74MBq |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 10mL vial |
| ATC code | V09HX |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-04-04 |
| Estimated end date | |
| Actual end date | 2019-05-10 |
| Shortage status | Resolved |
| Updated date | 2019-05-11 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600 MONTREAL, QUEBEC CANADA H4M 2X6 |
| Company contact information | [email protected] 1-800-811-5500 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-05-11 | English | Compare |
| v4 | 2019-05-10 | French | Compare |
| v3 | 2019-05-10 | English | Compare |
| v2 | 2019-04-16 | French | Compare |
| v1 | 2019-04-16 | English | Compare |
Showing 1 to 5 of 5